Powering Faster,
More Precise
Antibody Discovery
Opto B Discovery on the Beacon platform revolutionizes antibody discovery (AbD) by combining cutting-edge optofluidics, proprietary workflows, and best-in-class consumables.
The state-of-the-art workflows leverage up to 4 optofluidic chips to characterize single B cells and significantly reduce the time and cost needed to identify the most promising antibody lead candidates.
By harnessing the power of Opto® B Discovery workflows, the Beacon systems accelerate the discovery and testing process, making it more efficient and accessible beyond the reach of traditional methods.
This state-of-the-art instrument leverages a 2-chip single-cell optofluidic design that significantly reduces the time and cost needed to identify the most promising antibody lead candidates.
At the core of the Beacon system is a combination of optics and nanofluidics called optofluidics. The OptoSelect® chips replace typical well plates. Each OptoSelect chip contains thousands of NanoPen® chambers, which are like wells on a microplate. This is where cells are deposited, where they grow and where they are characterized using a myriad of proprietary Beacon Platform assay.
See how pioneers in AbD use our technology to speed up workflows, find the best lead
candidates and improve target-to-lead antibody selection.
Modules
Screening thousands of cells is an automated process on the Beacon system with our four workflow modules: Import, Culture, Assay and Export. These modules can be adapted, interchanged and deployed with a variety of single-cell assays to address specific applications and a variety of cell types.
Our software automatically identifies single cells and directs them into NanoPen chambers all at once. Chips are loaded with cells in less than 30 minutes.
As cells proliferate, nutrients diffuse in, waste diffuses out, and software images the chip continuously to count cells and calculate growth rate.
Test individual cells immediately and repeatedly in our NanoPen® chambers, instead of culturing for weeks to reach a minimum number of cells for assay.
Choose your cells of interest. Light patterns move them into position for export to a well plate.
Vanderbilt University delivered sequences of confirmed SARS-CoV-2 neutralizing antibodies to downstream manufacturing partners in just 18 days using this workflow. Two of these antibodies form the basis of AstraZeneca’s Evusheld antibody cocktail for the treatment of COVID-19, which was authorized for emergency use from 12/2021 to 1/2023.
These significant time savings not only enable a rapid response to emerging pandemics but can also deliver millions of dollars in enabled revenue and return on investment.
"The main reason why we employ the Beacon system here at Abveris is to enable deep characterization of single B cells in multiple sequential assays. Its design allows for precise control of the movement of cells, leaving you with the ultimate flexibility in assay design and, as a result, a higher screening resolution."
“In the long run, this technology will help us to solve complex problems that are too hard or expensive to solve with our current tools.”
of Antibody Discovery
The Beacon system can drastically reduce your AbD timelines and downstream costs by allowing you to bypass less promising candidates and devote your resources to only the most promising ones. It achieves this by functionally screening thousands of B cells in a single day and identifying the best candidates within hours, a process that traditionally takes months.
Opto B Discovery Workflow
Customize each workflow for your unique campaign goals. Choose from our wide range of reagents, chips, and workflow operations for the perfect balance of cost and performance. Mix and match our products with your expertise to get the most out of your discovery work.
Bypass lengthy and costly gene synthesis and cloning by directly incorporating BCR sequences into linear transcripts to transfect within days, not weeks.
- Unload: Desired single B cells are moved individually out of NanoPen chambers using light.
- Recover & Library Prep: Recover single B cells into standard 96 well plates for library preparation. Use our kits to amplify BCR amplicons for sequencing or customize to fit your downstream workstream.
- Sequence: Observe your recovered genotypic sequences with the deep phenotypic Beacon data in PrimeSeq BCR.
Your Antibody Discovery Research
Simply fill out the form to request a chat with one of our experts.
In a 30-minute call, we’ll be able to answer your questions, show you how the Beacon system can accelerate your AbD research, and share the most relevant datasheets & case studies for your research.